We will provide a general overview of the physiopathological role of INS in humans and their pharmacological properties as well as a systematic review of the available preclinical and clinical evidence regarding INS deficiency and supplementation in NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.